These evaluations support accurate diagnosis, help track baseline status, and allow clinicians to monitor progress throughout the course of peptide therapy, ensuring that treatment remains safe, appropriate, and effective over time
Recent case reports and small studies suggest a link between GLP-1 use and retained gastric contents
MOTS-c interactions with common medications are an important consideration before starting this metabolic peptide
As your body adapts and the medication accumulates in your system with weekly doses, the effects on appetite tend to become more pronounced
In many cases, starting with 250mcg per day is enough to stimulate healing without overstimulating pathways or triggering unwanted reactions
The tool of choice for small peptide doses.